Non-interventional study
Real-life data study of the French cohort of patients with Rendu Osler disease treatment with bevacizumab:the CoBevaRO study.
France
EU PAS number:
EUPAS1000000548
First published:
06/05/2025
StudyOngoing
Real-world effectiveness of pembrolizumab among patients with TMB-H advanced solid tumors (MK-3475-G34)
United States
EU PAS number:
EUPAS1000000542
First published:
06/05/2025
StudyOngoing
Prospective Registry-Based Study Evaluating the Effectiveness and Safety of Odevixibat in Participants With Alagille Syndrome (ALGS)
United States
EU PAS number:
EUPAS1000000441
First published:
06/05/2025
StudyOngoing
AN ITALIAN RETROSPECTIVE-PROSPECTIVE OBSERVATIONAL STUDY ON THE USE OF ZANUBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (AZALEA)
Italy
EU PAS number:
EUPAS1000000437
First published:
10/03/2025
StudyOngoing
Pergoveris patients’ profile and outcome response measurement in IVF/ICSI autologous cycles (PERFORM)
France
Germany
Greece
Italy
Norway
Romania
Spain
Switzerland
EU PAS number:
EUPAS1000000435
First published:
20/01/2025
StudyOngoing
Paternal exposure to valproate and the risk of neurodevelopmental disorders in children
Norway
Taiwan
EU PAS number:
EUPAS1000000417
First published:
14/04/2025
StudyOngoing
Characterize infections and outcomes developed in relapsed/refractory multiple myeloma (RRMM) patients treated with Teclistamab (SPOT)
Portugal
EU PAS number:
EUPAS1000000414
First published:
11/03/2025
StudyOngoing
Comparative Effectiveness of Sotorasib Versus Docetaxel Monotherapy in Second Line and Beyond (2L+) Among Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in the Cancer Analysis System Database in England (20240164)
United Kingdom
EU PAS number:
EUPAS1000000405
First published:
16/04/2025
StudyOngoing
Effectiveness of ABRYSVO® maternal respiratory syncytial virus (RSV) vaccine against RSV in infants in Western Pennsylvania (CASSATT)
United States
EU PAS number:
EUPAS1000000389
First published:
17/02/2025
StudyPlanned
ConTTRibute: A Global Observational Multicenter Long-Term Study of Patients with Transthyretin (TTR)-Mediated Amyloidosis (ATTR amyloidosis)
Brazil
Bulgaria
Denmark
France
Germany
Israel
Italy
Netherlands
Portugal
Spain
Taiwan
United States
EU PAS number:
EUPAS1000000381
First published:
07/05/2025
StudyOngoing